Home LiteratureArticle Details
PMID: 3257251 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells.

The Journal of experimental medicine ·Vol. 167 ·No. 1 ·1988-01-01 ·Pages 15-29

Vujanovic NL, Herberman RB, Maghazachi AA, Hiserodt JC

Abstract

A simple method for the purification and rapid expansion of large granular lymphocytes into cells with efficient broad antitumor cytotoxicity after stimulation by human rIL-2 is described. Nylon-wool nonadherent splenic mononuclear leukocytes from Fischer 344 rats were cultured in medium containing 1,000 U/ml rIL-2. The initial response of a small subpopulation of cells (less than 2%) to rIL-2 was their adherence to the plastic surface. This response was noted as soon as 2 h after addition of rIL-2. 2-h rIL-2-activated plastic adherent lymphocytes were 90-98% LGL, expressed surface markers characteristic of rat NK cells (OX8 [CD8]+, asialo GM1, laminin+, OX19 [CD5]-, R1-3B3 [CD5]-, W3/25 [CD4]-, OX39 [CD25]-, Ia-, and Ig-), and expressed very high levels of cytotoxicity against YAC-1 target cells. In addition to the above markers, plastic-adherent LGLs obtained at 24, 48, or 72 h progressively expressed Ia surface antigens, but were not phagocytic and contained less than 1% monocytes/macrophages by morphology. When 24- or 48-h plastic-adherent LGL/NK cells were cultured over 3-4 d in rIL-2, the cells expanded between 30- and 100-fold, reaching densities between 2-3 X 10(6) cells/ml. These rapidly expanding LGL/NK cells also generated very high levels of LAK activity (including lysis of fresh NK-resistant solid tumor cells), expressed a phenotype characteristic of activated rat NK/LAK cells, and incorporated [3H]TdR into DNA. This technique not only provides a novel method for the purification of LGL/NK cells for in vitro studies but also provides a means for the rapid expansion of highly purified cells with high levels of broad antitumor (LAK) cytotoxicity.

MeSH Terms
Animals Antigens, Surface/analysis Cell Separation Cells, Cultured Cytotoxicity Tests, Immunologic Interleukin-2/pharmacology Killer Cells, Natural/drug effects,immunology Male Phenotype Rats Rats, Inbred F344/immunology Recombinant Proteins/pharmacology Tumor Cells, Cultured
Chemicals
Antigens, Surface Interleukin-2 Recombinant Proteins
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Vujanovic N L
Pittsburgh Cancer Institute, Pennsylvania.
Herberman R B
Maghazachi A A
Hiserodt J C
References (18)
18 references, click to expand
  1. Induction of polyoma specific transplantation antigenicity in Moloney leukemia cells.
    Exp Cell Res. 1965 Oct;40(1):208-12 PMID: 4284528
  2. Murine lymphokine-activated killer (LAK) cells: phenotypic characterization of the precursor and effector cells.
    J Immunol. 1986 Jul 15;137(2):715-22 PMID: 2873187
  3. Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells.
    J Immunol. 1981 Jul;127(1):282-7 PMID: 7240744
  4. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
    J Immunol. 1985 Feb;134(2):794-801 PMID: 3871216
  5. Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells.
    J Immunol. 1985 Feb;134(2):802-7 PMID: 3917475
  6. Phorbol ester-induced lymphocyte adherence: selective action on NK cells.
    J Immunol. 1985 Apr;134(4):2215-22 PMID: 3855930
  7. Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.
    J Immunol. 1985 Apr;134(4):2783-9 PMID: 3871818
  8. Expression of a laminin-like substance on the surface of murine natural killer (NK) lymphocytes and its role in NK recognition of tumor target cells.
    J Immunol. 1985 Aug;135(2):1484-7 PMID: 4008929
  9. Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes.
    Annu Rev Immunol. 1986;4:681-709 PMID: 3518753
  10. Lymphokine-activated killer cells. Analysis of progenitors and effectors.
    J Exp Med. 1986 Oct 1;164(4):1193-205 PMID: 3093626
  11. Proliferation of human peripheral blood lymphocytes induced by recombinant human interleukin 2: contribution of large granular lymphocytes and T lymphocytes.
    Cell Immunol. 1986 Oct 15;102(2):261-72 PMID: 3100057
  12. Precursor phenotype of lymphokine-activated killer cells in the mouse.
    J Immunol. 1987 Jun 1;138(11):3635-9 PMID: 3108370
  13. Studies on lymphokine activated killer cells in the rat: analysis of precursor and effector cell phenotype and relationship to natural killer cells.
    Prog Clin Biol Res. 1987;244:137-46 PMID: 2958869
  14. Adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2.
    Important Adv Oncol. 1986;:55-91 PMID: 3330541
  15. Large granular lymphocyte leukemia. A heterogeneous lymphocytic leukemia in F344 rats.
    Am J Pathol. 1983 Apr;111(1):1-10 PMID: 6837719
  16. Response of resting human peripheral blood natural killer cells to interleukin 2.
    J Exp Med. 1984 Oct 1;160(4):1147-69 PMID: 6434688
  17. Adjuvant immunotherapy of established murine renal cancer by interleukin 2-stimulated cytotoxic lymphocytes.
    Cancer Res. 1986 Jul;46(7):3358-63 PMID: 3486710
  18. A rapid method for the isolation of functional thymus-derived murine lymphocytes.
    Eur J Immunol. 1973 Oct;3(10):645-9 PMID: 4587740
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1988-01-01
Pages
15-29
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2188812
Subset
IM
Grants
NCI NIH HHS · CA-43765 · United States
NHLBI NIH HHS · HL-37638 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]